Zedur Enerji Elektrik Üretim Anonim Sirketi (IST:ZEDUR)

Marinus Pharmaceuticals Balance Sheet

Financials in millions TRY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	37.15	11.67	11.01	15.14	1.32	1.76
Short-Term Investments	0	0	-	-	-	3.62
Cash & Short-Term Investments	37.15	11.67	11.01	15.14	1.32	5.38
Cash Growth	1745.40%	6.04%	-27.27%	1050.88%	-75.56%	-21.41%
Accounts Receivable	33.04	15.3	18.99	24.02	11.76	0.79
Other Receivables	0.24	0.36	0.12	4.01	4.62	8.99
Receivables	33.28	15.66	19.11	28.03	16.37	9.78
Inventory	-	-	5.91	2.09	2.54	-
Prepaid Expenses	6.1	1.3	1.4	0.91	0.08	-
Other Current Assets	0.45	5.62	13.85	9.06	5.95	304.02
Total Current Assets	76.99	34.26	51.28	55.23	26.38	319.18
Property, Plant & Equipment	2,308	2,110	2,152	1,379	498.53	68.87
Long-Term Investments	-	-	-	-	14.88	14.88
Other Intangible Assets	0.02	0.02	0.04	0.04	0.01	0.01
Other Long-Term Assets	41.15	37.41	35.73	5.36	5.25	3.59
Total Assets	2,448	2,182	2,239	1,440	545.05	406.51
Accounts Payable	5.79	3.93	0.87	2.79	5.32	1.26
Accrued Expenses	1.59	12.35	13.23	12.24	0.76	0.6
Short-Term Debt	72.7	69.71	68.95	10.05	8.78	0.04
Current Portion of Long-Term Debt	82.11	58.69	65.84	63.1	20.47	-
Current Portion of Leases	4.75	2.96	2.77	-	-	-
Current Income Taxes Payable	-	-	-	3.12	0	-
Current Unearned Revenue	0.66	0.67	0.9	2.59	0.82	0.08
Other Current Liabilities	14.69	4.58	5.04	3.98	18.59	347.29
Total Current Liabilities	182.27	152.9	157.6	97.87	54.74	349.26
Long-Term Debt	217.12	179.35	259.27	236.36	118.95	-
Long-Term Leases	6.64	6.79	10.26	-	-	-
Long-Term Deferred Tax Liabilities	96.32	91.34	97.61	129.89	34.16	4.92
Other Long-Term Liabilities	0.73	-	2.19	-	0	0
Total Liabilities	505.93	432.97	528.74	465.26	208.22	354.18
Common Stock	174.75	174.75	25	25	25	25
Additional Paid-In Capital	190.78	173.34	173.34	120.06	12.17	12.17
Retained Earnings	493.22	423.72	384.93	80.56	93.34	-180.99
Comprehensive Income & Other	1,085	978.5	1,123	742.1	205.62	195.8
Total Common Equity	1,943	1,750	1,707	967.72	336.13	51.98
Minority Interest	-1.32	-1.57	3.39	7.13	0.69	0.35
Shareholders' Equity	1,942	1,749	1,710	974.86	336.83	52.33
Total Liabilities & Equity	2,448	2,182	2,239	1,440	545.05	406.51
Total Debt	383.32	317.5	407.08	309.51	148.2	0.04
Net Cash (Debt)	-346.17	-305.82	-396.07	-294.37	-146.88	5.35
Net Cash Growth	-	-	-	-	-	-21.55%
Net Cash Per Share	-1.98	-1.75	-2.27	-1.68	-0.84	0.03
Filing Date Shares Outstanding	174.75	174.75	174.75	174.75	174.75	174.75
Total Common Shares Outstanding	174.75	174.75	174.75	174.75	174.75	174.75
Working Capital	-105.29	-118.64	-106.32	-42.64	-28.36	-30.09
Book Value Per Share	11.12	10.02	9.77	5.54	1.92	0.30
Tangible Book Value	1,943	1,750	1,707	967.68	336.13	51.97
Tangible Book Value Per Share	11.12	10.02	9.77	5.54	1.92	0.30
Land	748.39	680.62	680.62	330.38	34.91	33.63
Buildings	-	-	3.25	4.45	-	1.5
Machinery	1,879	1,706	1,699	1,179	481.42	9.01
Leasehold Improvements	6.52	5.92	5.92	4.1	0.97	0.63

Source: S&P Global Market Intelligence. Standard template. Financial Sources.